Author: Justin Mckibben
Overprescribing of powerful prescription medications is just one part of how the current American opioid crisis came to be. While incredibly dangerous synthetic drugs like fentanyl came pouring in from across the globe, the pharmaceutical industry right in our own backyard thrived off of the devastation it was helping create. And as more people became aware of how prescription drugs were contributing to one of the worst drug epidemics in the country’s history, Big Pharma has come under fire for a number of things over the years. To name a few, we’ve seen arguments against drug companies for:
With recent reports, such as the explosive piece of 60 Minutes last month, we have also been exposed to the corruption, greed and a disregard for the well-being of the consumer.
The Big Pharma propaganda machine has paid out countless dollars for criminal and civil settlements over the years. Now even state officials are resorting to lawsuits against drug manufacturers in the fight against the ongoing opioid crisis.
So how did all this happen? How deep does the Big Pharma propaganda go? Some of this you might already know, but some of it might actually surprise you.
In case you didn’t know, the pharmaceuticals and health products industry spends the most money on lobbying politicians. And not even by a little.
Big Pharma and Health Products spent $3,714,580,815
That means that Big Pharma spends:
- $1,134,783,913 more than 2nd place- Insurance Companies
- $1,717,237,691 more than Oil/Gas Companies
The pharmaceutical industry, including dealers of medical products and nutritional/dietary supplements, is consistently a top contributor more to federal campaigns than any other industry.
In essence, drug companies spend big money on politics.
Whether we can always see it or not, this kind of financial incentive is more than likely playing into our current work on policy. For example, moves to pass legislation earlier this year were called into question by one source who pointed out 13 senators who were trying to push through a bill that would benefit the health insurance and pharmaceutical companies were receiving hundreds of thousands of dollars in contributions from these companies between 2010 and 2016, including:
- Utah Republican Senator Orrin Hatch led the way with more than $471,000
- Kentucky Republican Senator Mitch McConnell with over $433,00 in donations
FUN FACT- Many lobbyists working on behalf of Big Pharma companies have previously held government jobs.
Truthfully, drug companies spend several years before a drug even makes it to the market on planning a strategy for selling it to you. Part of that strategy is proving drugs have value for treatment. However, according to some industry insiders, a lot of the time there is not enough comprehensive data to prove that value.
What you might also find surprising is that some of the earliest information drug companies have published about their products aren’t actually from credible sources. Ad agencies will hire writers to produce articles on behalf of the drug maker highlighting benefits of a drug. But the data is often cherry-picked and incomplete.
These articles are then sold to the public as ‘scientific’ because they are printed and published by some of the biggest scientific and medical publications, such as the New England Journal of Medicine. Those articles are then picked up by television and other news sources.
So essentially, drug companies often team up with marketing companies to fool not just doctors, but the public into thinking their product provides something that has yet to be proven. Big Pharma propaganda corrupts the research into their drugs and makes people believe their products are safer and more effective than they are.
For more important information on the dangers of prescription drugs, download our FREE E-BOOK “Big Secrets of Big Pharma: Why They Secretly Hope You Get Hooked”
DOWNLOAD FREE E-BOOK
Big Pharma’s Billions in Ads
It isn’t just behind the scenes that Big Pharma propaganda takes place. Drug makers spend around $21 billion a year just to pedal products through advertising. One big problem for Americans is that many of their promotional techniques have been called out for being false advertising or misleading, to say the least.
- 2015, the industry spent a record-breaking $5.4 billion of direct-to-consumer ads alone.
- The same year, Americans spent over $450 billion on prescription drugs.
Some sources indicate there are about 80 drug advertisements per hour. While drug companies want people to think it is raising awareness, it is most definitely a commercial to sell you something.
Many pharma companies even have deep financial ties to medical communication companies (MCC) like WebMD or Medscape. This is just one more way they can influence physicians and consumers without people realizing the drug makers are funding the information.
Doctors Recruiting Doctors
But the drug makers don’t stop with recruiting politicians to support them. They also utilize doctors to help them push their products. The main target audience in most of the campaigns pushed by Big Pharma propaganda is not necessarily the consumer as much as it is the person who writes the prescriptions.
Drug companies giving kickbacks to doctors is nothing new.
So drugmakers create an advisory board, where some of the most successful and well-respected doctors are put on the payroll with huge payoffs to help drug companies design a marketing campaign that will help promote the drugs to other doctors. Once these doctors have helped highlight the best ways to convince other physicians these drugs work, they themselves validate the drug in a way that encourages other doctors to prescribe the drug.
Drugs to Treat Drugs
A while back there was an ad that ran during the Superbowl that caught the attention of a lot of people. It was an ad selling an anti-constipation drug for those so dependent on prescription opioids that they were suffering from constipation as a side effect.
This is another huge problem with how drugs are marketed to us… in tandem.
Instead of suggesting an alternative treatment, drug companies want to give you more drugs to combat the effects of other drugs. Doctors will often prescribe a second medication for no other purpose than to treat the effects of the first medication. Big Pharma propaganda can literally sell you the illness and the medicine in the same marketing campaign. A 2012 study published in the journal Annals of Family Medicine describes this as “prescribing cascade”.The study indicates that the practice of using drugs to treat problems with other drugs is a key component to the heavy reliance on pharmaceuticals in healthcare.
Another devastating way this has taken place is when doctors prescribe powerfully and potentially habit-forming narcotic medications to combat illicit drug use and substance use disorder. Heroin addicts are being treated with other strong narcotics, which can actually have their own withdrawal symptoms and side effects. They even highjacked the opioid overdose antidote and several makers gouged the prices to offensive new heights during the rise of the opioid epidemic.
Drug Companies Abuse of Americans
Now let us be fair; modern medicine does provide us with some life-saving resources that can be paramount to the health and wellness of our population. Thanks to great strides in medicine doctors are able to treat some conditions or illnesses that were once thought of as a death sentence. Today, we have some of the greatest opportunities to receive quality care with innovative and well-researched treatments.
However, the fact remains that drug companies have been caught red-handed more than a few times misrepresenting their products, hiding the side-effects, falsely advertising their benefits and even recently some huge names in pharmaceuticals have been accused of bribery and racketeering to sell potent and extremely dangerous drugs.
So, what can be done?
- We can take a closer look at how Big Pharma propaganda influences or elected representatives and their decisions on policy.
- We can pay attention to how the information provided by pharmaceutical companies or marketers is not always as reliable as it may seem.
- Look into excessive advertising for potent drugs
- Do more to combat drug makers from paying doctors to promote their drugs to other doctors.
- Pursue other forms of treatment that don’t require expensive and powerful drugs.
When it comes to drug abuse, maybe we shouldn’t let the drug companies continue to make massive profits from a problem they have a large hand in creating. There needs to be more commitment to finding alternative treatments that don’t rely so heavily on drugs in order to help people get healthy.
Holistic drug addiction treatment is a unique and effective way of helping people struggling with substance use disorder. The fact that powerful drugs help cause addiction, let us not forget the value of offering healing options that don’t require more drugs. Building a strong foundation with personalized therapy and innovative treatment opportunities helps thousands of people all over the nation overcome addiction. Palm Partners Recovery Center is committed to providing quality care for those dealing with drug abuse, whether it is illicit drugs or prescription drug dependence. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-800-951-6135
(This content is being used for illustrative purposes only; any person depicted in the content is a model)
Author: Justin Mckibben
You may remember back in early 2016 the pharmacy organization Walgreens announced two programs to address key issues in the opioid crisis.
- Safe medical disposal kiosks for unused prescription drugs
- Narcan expansion programs
By the end of 2016, Walgreens had expanded access to the opioid overdose antidote without the requirement of a prescription to 33 states and the District of Columbia. The Narcan opioid overdose antidote, also known by the generic name Naloxone, is a nasal spray that is utilized all over the country as a means to revive someone experiencing an opioid overdose.
Now, this life-saving compound is becoming even more accessible, as Walgreens is announcing the Narcan opioid overdose antidote will now be available at all of its over 8,000 pharmacy locations!
Pharmacies Stepping Up to the State of Emergency
This new move to combat the opioid epidemic comes at a crucial time. The epidemic continues to claim lives every day, with recovery advocates and government officials rallying for more resources to fight the problem.
Today, Thursday, October 26, 2017, the nation is expecting President Donald Trump to officially declare the opioid crisis a public health emergency at a scheduled White House event.
According to Rick Gates, Vice President of Walgreens,
“By stocking Narcan in all our pharmacies, we are making it easier for families and caregivers to help their loved ones by having it on hand in case it is needed.”
The company offers Narcan opioid overdose antidote without a prescription in 45 states and is willing to work with the remaining states to make to include them.
Of course, the fight for more availability of Narcan and Naloxone has been going on for some time. However, it seems as the country is calling for more sweeping action from government officials; pharmacies are taking it as a call to action themselves. Rick Gates went on to say,
“As a pharmacy, we are committed to making Narcan more accessible in the communities we serve.”
Walgreens also says it will inform customers about the Narcan opioid overdose antidote if they receive drugs with more than 50 morphine milligram equivalents (MME). This is actually a recommendation from the CDC.
It isn’t just Walgreens either. CVS pharmacy has expanded access to Narcan and other products that contain naloxone. CVS reportedly has been offering prescription-free naloxone in up to 43 states as of last month. CVS pharmacies have said that its locations “in most communities have naloxone on hand and can dispense it the same day or ordered for the next business day.”
Big Pharma’s Role
Big Pharma wholesaler AmerisourceBergen is also helping in these efforts. AmerisourceBergen is now distributing Narcan demo devices at no cost to Walgreens pharmacists. These demo devices will help with instructing patients on how to administer the medication safely and effectively.
Robert Mauch, Executive Vice President & Group President, Pharmaceutical Distribution & Strategic Global Sourcing for AmerisourceBergen, states,
“At AmerisourceBergen, we strive to provide our customers the highest quality care and support so they can ultimately enhance the lives of patients in their communities,”
“We recognize the important role we play in addressing the opioid epidemic, and our collaboration with Walgreens is another key milestone to supply our customers with access to lifesaving initiatives and emergency medications that can help keep individuals safe across the country.”
Ironically, AmerisourceBergen just so happens to be one of the three largest drug distributors that were mentioned in the recent 60 Minutes interview with ex-DEA agent Joe Rannazzisi. In the segment that has since caused a major uproar, Rabbazzisi said companies including AmerisourceBergen controlled probably 85%- 90% of drugs that went “downstream” and ended up on the streets.
This might not be what Mauch meant by “recognize the important role we play”, but at least it seems like AmerisourceBergen is taking steps to become part of a solution.
Meanwhile, Adapt Pharma, the manufacturer of Narcan Nasal Spray, celebrates this action by Walgreens to expand naloxone and Narcan access. Seamus Mulligan, CEO at Adapt Pharma states,
“This action is an important milestone and we applaud Walgreens initiatives to improve access to Narcan Nasal Spray in communities across the U.S.,”
“This effort, combined with the opportunity for patients and caregivers to obtain Narcan Nasal Spray without an individual prescription in 45 states, is critical in combating this crisis.”
America is working hard to find the right path on the road to recovery from the devastating opioid crisis. It is crucial that we make every possible resource available to help save lives. With opioid overdose killing an estimated 91 people every day, the need for this life-saving medication could not be more evident.
Beyond reversing the effects of an overdose, there is more we need to do. While having access to Narcan and naloxone can help tremendously, we also need to promote recovery and addiction treatment resources. Preservation of life is important, but giving people the help they need to live a happier and healthier life should also be a priority in the fight to overcome the opioid crisis. Palm Partners Recovery Center believes in actively providing the best in innovative and holistic treatment opportunities, to help transform lives. If you or someone you love is struggling with substance abuse or addiction, we want to help. Please call toll-free now.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
The Global Commission on Drug Policy (GCDP) is an international institution of global leaders and intellectuals working to help study and inform initiatives on addressing drug use all around the world. This think tank offers recommendations concerning drug use and its consequences for societies across the globe.
The GCDP consists of members from various nations, including but not limited to:
- The United States of America
- The United Kingdom
Former U.S. President Jimmy Carter wrote an op-ed in The New York Times explicitly endorsing the recommendations of the Global Commission on Drug Policy, and the group has released various reports over the years focusing on the efforts to curb the spread of drug abuse.
Recently the GCDP released a position report on the North American opioid epidemic. In this report, the commission issues recommendations that appear to endorse the expansion of harm reduction techniques to battle the ongoing crisis.
The Turning Point for America
According to the GCDP’s new report, North America is at a turning point in the way that drug addiction is viewed. This is not too much of a surprise, considering now more than ever there has been a push for a more compassionate perspective on drug use and addiction. America now finds itself in a unique position where the stigma that has so long been attached to addiction is starting to be abandoned, and more progressive action is being taken.
Now the Global Commission on Drug Policy believes national policymakers should take advantage of this unique opportunity to reduce opioid-related deaths through harm reduction. In the report the authors state:
“While in recent years media and politicians have been more open to viewing addiction as a public health problem, leadership is needed to turn this into an urgent and commensurate response to the crisis,”
One way that the Global Commission on Drug Policy ideals clashes with that of the Trump administration, currently steering drug policy in America is that the GCDP does not endorse the old policies of the War on Drugs.
GCDP vs War on Drugs
Back in June of 2011, the GCDP stated:
“The global war on drugs has failed, with devastating consequences for individuals and societies around the world.”
Again, this recent report echoes that sentiment, saying that attempting to cut off the opioid supply is not the answer. The new report notes how this approach has been tried before, as the first reactions to the opioid epidemic were to limit prescriptions and to introduce pills that were harder to manipulate.
The report goes on to note that this response drove people to use cheaper and often much more potent street drugs instead of prescription pills. Fentanyl is one of the worst synthetic opioids to contribute to the outbreak of overdoses and deaths across the country.
The Global Commission on Drug Policy says cutting off the supply of opioids into the country cannot be effectively executed until after supportive measures are put in place. This means supporting not only both people battling addiction but also people with chronic pain. The report insists:
“The aim is to achieve the right balance in regulation to provide effective and adequate pain care, while minimizing opportunities for misuse of these medications.”
To reduce the harmful impacts of opioids, the commission calling for the acceptance and implementation of harm reduction strategies.
The Global Commission on Drug Policy Suggests Harm Reduction
So if they are saying that the War on Drugs did not work, and neither will bulking up borders, then what will?
Well, according to the GCDP, harm reduction is the right move. The new report calls on American lawmakers to promote programs like:
Naloxone Distribution and Training
As the opioid overdose antidote, Naloxone is an invaluable tool to have in the fight against the opioid epidemic in America, but the price for the drug continued to skyrocket as the epidemic got worse. Making it more available could give access to and train people with life-saving medication to thousands or even millions more.
Safe locations where IV drug users can trade old, contaminated needles for new, sterile needles to help prevent the spread of blood-borne illness like HIV.
Facilities where drug users can go to use their drugs with sterile equipment safely, reducing the number of overdose deaths by providing a place free of punishment for them to use with medical emergency resources on site.
These kinds of programs would allow for users to check their drugs for the presence of any unknown substances it may have been diluted with. For example, most fentanyl users do not know they are using fentanyl.
Decriminalizing Drugs in America
In another aspect of the report, GCDP also makes a much more revolutionary and more radical suggestion that many may consider qualifying as harm reduction: decriminalization.
The report states:
“The Global Commission on Drug Policy also calls for the elimination of illicit drug markets by carefully regulating different drugs according to their potential harms. The most effective way to reduce the extensive harms of the global drug prohibition regime and advance the goals of public health and safety is to get drugs under control through responsible legal regulation.”
With this philosophy in mind, the GCDP made two more drastic recommendations:
- End the criminalization and incarceration of people who use drugs nation-wide in Canada and the United States.
- Allow and promote pilot projects for the responsible legal regulation of currently illicit drugs including opioids.
The idea is that by decriminalizing drugs, they can bypass criminal organizations and ultimately replace the current black market.
“Do not pursue such offenses so that people in need of health and social services can access them freely, easily, and without fear of legal coercion,”
We have begun to see a watered-down variation of this kind of strategy with many Police Assisted Addiction and Recovery Initiative (PAARI) programs, where law enforcement is helping addicts get into treatment instead of arresting them when they ask for help.
Better Treatment Research
The report insists that more research is necessary in a few critical areas in order the effectively address the opioid crisis and the overall drug problem in America.
One of the key points of research the GCDP proposes is for finding the most effective treatments for addiction, specifically to prescription opioids. In addition, the report shows support for medication-assisted treatment (MAT) and opioid substitution therapy (OST) as a means to preserve life to assist in the recovery process. While these programs are met with some of the same contentions as safe injection sites or decriminalization, the commission seems adamant about using harm reduction to keep people alive long enough to get better.
Michel Kazatchkine, a doctor and commission member, said in a recent interview:
“Repression is harmful. Wherever repressive policies are in place, people will not be in the best condition to access services.”
While he and other commission members are in no way naïve to the fact there is no way decriminalization will happen at the federal level soon in the U.S., they remain hopeful that states or cities will make decisions which don’t require federal approval, or for which they are willing to enter to fight with the federal process.
Overall, the hope of the GCDP is that these suggestions, coming from a group of world leaders fully invested in understanding the issue, will convince American and Canadian lawmakers to take a progressive approach to the crisis.
What could some of these changes mean for those trying to recover from opioid abuse? How could some of these ideas change the way addiction treatment operates within America?
One thing is for certain, in fighting opioid addiction, whether as a society, as a family or as an individual, there needs to be compassion and action. It takes courage and it takes a degree of uncertainty. But with the right resources, there is hope for a greater future. If you or someone you love is struggling with substance abuse or addiction, please call toll-free now.
CALL NOW 1-800-951-6135
(This content is being used for illustrative purposes only; any person depicted in the content is a model)
Author: Justin Mckibben
As a recovered alcoholic and drug addict it is a truly gratifying experience to work in the field of addiction treatment, and even more so to work for the company that helped save my life. Palm Healthcare Company is a truly unique organization that is committed to compassionate and effective treatment, and there is no telling how many lives have been positively and permanently impacted because of what they (or should I say WE) do. It is an amazing thing to be a part of, and a worthy cause to work for.
That is a crucial part of addiction treatment and recovery; work. The real work is for those trying to recover.
One thing I notice about some clients these days in addiction treatment is less of a willingness to do that work. When I was getting treatment everyone seemed desperate to do anything that would make a difference in their lives. Yet these days I see some people who act as if the program is supposed to do the work for you.
Is our current addiction treatment culture somehow convincing people they don’t have to do the work for real change? How can we work together to change it?
On to the Next One
The culture surrounding addiction treatment and recovery has changed. Breaking the stigma surrounding addiction is a critical step in helping more people get the help they need. Expanding availability is amazing and we should all work toward making even more treatment options available. It could help save thousands of the people who die every year from overdose and drug-related issues.
However, it also seems some have the idea that they will always be able to find some treatment program, legitimate or not, willing to take them. This shift toward people thinking they can just keep hitting restart has almost watered down the opportunity or having a fresh start in the first place.
This might be comforting to some people; the idea that if they don’t like one program they have options. But ultimately what people have to understand is that a treatment program can only be effective if you participate in it. You can go to a dozen different programs and still get very little value if you do not show up and try to engage in the recovery process.
We can complain about the “revolving door” metaphor all we want, but if people aren’t going to take steps toward something better, they are volunteering for more of the same.
Sadly, some people still think there is always the next place. This is part of the reason programs that put an emphasis on relapse prevention and aftercare are so important. Continued accountability can help people maintain their progress without having a nonchalant attitude about the process.
What if you never make it to the next place? Regardless, why wouldn’t you want to make this place the last place?
Of course, both sides of the culture have to take steps. Public officials, treatment providers, and advocacy groups should continue working together to better enforce regulations for treatment, eliminating criminal operators and protecting client rights.
Taking it Serious
This point actually goes hand in hand with the first. As more people are exposed to more resources they might take the availability of new opportunities for granted.
In an industry obstructed by shady operators, people can also become jaded. If you have sought treatment with programs that provide little to no real resources or solutions you might stop taking addiction treatment seriously, even if you get a great opportunity with a reputable and innovative program.
If you don’t take the treatment seriously you probably won’t take your recovery seriously, either.
Of course no one is naïve enough to say the opioid epidemic and overdose rates aren’t serious. But if we know how bad it is; if we see the devastation caused in our own lives or those we love, why don’t we appreciate that gift of desperation and commit to doing the work? Has the addiction treatment client culture taught people that it doesn’t really matter? Do clients think recovery isn’t that serious once you get past the withdrawals or the troubles you get caught up in while using or drinking?
These are valid and sometimes difficult hurdles, but many still say that is the easy part. The rest of the work comes with committing to a treatment plan and following through.
Getting Back to Gratitude
I think this may be the core concept. The culture change within the recovery community is in many ways constructive, but it also has taken some of the raw truth out of the situation for some people.
I think we should try to get true gratitude back into the culture of addiction treatment. We should be grateful that we have more resources than ever, with more professionals working to revolutionize recovery. Let us be grateful that on a national level the world is starting to have greater respect and understanding for those suffering from addiction. We should be grateful for the opportunity to get help when we finally get it because a lot of people never do.
But to the client that contributes to the recovery culture- always remember that true gratitude takes action.
If you say you are grateful to be in treatment, take your treatment seriously and participate. If you are grateful for an opportunity, don’t waste it because you think you can bank on another one right around the corner. So if you want something different, do something different instead of thinking you need to go somewhere different.
And let us all be grateful that there are more opportunities for people to find a solution that could save their life.
Cultivate Better Culture
As holistic treatment providers, Palm Partners Recovery Center will continue working to support recovery professionals within the Palm Healthcare Company organization and within our industry; to strive for better services and to unite against illegitimate operators.
But we as alcoholic or addicted individuals in recovery also need to be willing to put in some work. For anyone like me, who spent years abusing substances to the point it felt like my life depended on it, it is going to take some real work to get better.
If we as individuals want to advocate for recovery, let us advocate that people do the work. Let us appreciate the value of mental health care. Let us appreciate the value of addiction education and cognitive behavioral therapy. We can cultivate a better culture for ourselves; as clients and as providers.
WE means all of us. It means the healthcare providers, the individuals in recovery who have been lucky enough to get this far and the addicts and alcoholics out there still suffering. Addiction treatment works; recovery works… if WE do.
I punch that clock every day. I’m grateful for this work, so I do it. But WE can do more.
As a culture, we have the power to transformed and elevate the lives of millions of people everywhere through recovery from drugs and alcohol. It takes work. If you are ready to take that step and work for a better future, Palm Partners wants to help. Please call toll-free now.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
When we talk about national addiction recovery, what we mean is acknowledging how we as a country and a culture are recovering in our communities. How are we supporting those in addiction treatment? What services are we making available? How is our economy recovering? What are we doing to prevent the spread of addiction?
So if we are taking away resources that not only treat those already struggling, but also prevent more people from suffering, how do we expect to ever escape the devastation caused by the opioid epidemic and rise of overdose deaths?
One of the most divisive issues facing America today is access to healthcare and the extent to which health coverage should or should not be provided. The debate has gone on for a long time, and in the shuffle of each proposal, it seems mental health and addiction services are constantly threatened. Recently there have been more attacks on addiction treatment access. So how is the possibility of more decreases in health coverage going to hurt national addiction recovery?
The Parity Protections
Once upon a time in 2008, the Mental Health Parity and Addiction Equity Act (MHPAEA) created guidelines that required health insurers to treat mental health and addiction coverage exactly the same as they would with medical and surgical care options. So this means that prior to the MHPAEA those who were lucky enough to have health insurance still could not be guaranteed to receive equitable benefits for mental health or substance abuse care.
These protections were even further expanded by the Affordable Care Act (ACA) and legislation put forth by Congress in 2016 with the 21st Century Cures Act, which includes tougher enforcement of parity requirements.
Since the Trump administration stepped in adamantly proclaiming the goal or repealing and replacing the ACA there has been a lot of concern about whether or not any new proposals will decrease health coverage for mental health and addiction services. Many addiction and mental health advocates worry that parity protections and enforcement will also lose their power.
As of yet, politicians are still hoping for a compromise that will keep the protections and resources for treating addiction and mental health intact.
BCBS Cuts Mental Health Coverage
One instance of concerning changes in policy has come out of Minnesota. Just this September the largest insurance carrier in the area, Blue Cross Blue Shield, is making drastic decreases to payments to mental health providers.
We are talking about cuts in addiction and mental health coverage to the tune of that’s 33%!
This decision came after a recent survey showed that the individual therapy costs of Minnesota had exceeded the national average for the last two years. But mental health professionals immediately spoke out against this move. Protests actually took place on Thursday the 14th outside the headquarters of Blue Cross Blue Shield in Eagan, MN. Many advocates and protesters are saying these kinds of cuts will put mental health clinics out of business.
The insurance provider is now under fire as caregivers insist this change will discourage necessary, extended psychotherapy services. People in Minnesota see decisions like that of BCBS as being a violation of the protections offered by parity.
If this kind of policy shift within insurance providers becomes a trend, we could see a dramatic decrease in the people getting substance abuse and mental health treatment. These changes can hurt our national addiction recovery by slowly cutting off the people who need every chance they can get, especially during a devastating opioid epidemic.
Threats within Medicaid
Believe it or not, Medicaid is currently the single largest payer for behavioral health services in America. Threats to the Medicaid health coverage of services like this could do critical damage.
At one point the Trump administration and congressional leaders seemed partial to the idea of turning Medicaid into a block grant program. This strategy would give states a fixed amount of money to provide healthcare for low-income residents. However, policy experts say that means states would have to:
- Reduce eligibility
- Narrow the scope of benefits
- Impose cost-sharing requirements
All of which would also impact the number of people seeking substance abuse and mental health treatment.
Recently GOP representatives and the Trump administration began the work of fundamentally altering state Medicaid programs. Some of these new requirements include governors pushing for:
So again, there is the very real possibility of more hurdles being put in-between those who need help and the already limited resources available to them.
Stigma Influencing Policy
The bigger part of this issue is that these shifts are happening in a way that shows how stigma is influencing policy. We are only further hurting our national addiction recovery by letting this idea that addiction is a moral failing or class issue limit what we are willing to provide to those who need help.
The reason behavioral and mental health services are so crucial is because the cause of addiction is not just the drugs themselves. The vast majority of recovery advocates endorse the concept that addiction develops from multiple factors, such as:
- Lack of access to resources
- Poor social networks
So in fact, by limiting coverage to mental health services, the problem could be magnified.
Mental health services like behavioral therapy being lost with a decrease in coverage means that more children and young adults could go without the support systems. What this does is puts more people in the exact circumstances where we see substance abuse and addiction grow.
So in essence, not only could these constant threats to addiction and mental health coverage be taking away treatment for those already addicted, but it also takes away from prevention programs in communities that fight to keep addiction rates down.
National Addiction Recovery Effects Everyone
If we have any hope of having sustainable national addiction recovery then it is vital that our country continues to push for mental health parity in every discussion about healthcare. If we ever hope to overcome the demoralization of communities we have to fight for mental health and addiction services.
This isn’t about treating the individual’s symptoms with just medications either. Access to other crucial elements like housing, medical care, and basic preventative measures all contribute to the overall mental health of any individual.
When people have better access to the specific levels of care they need, we empower them to contribute to the better communities we need for healthy nation-wide recovery.
People struggling with substance abuse and mental health disorders deserve comprehensive and compassionate treatment, and we should all fight to protect coverage that makes treatment more available. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-800-951-6135